)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Cartesian Therapeutics
Cartesian Therapeutics (RNAC) investor relations material
Cartesian Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary12 Jun, 2026
Opening remarks and agenda
CEO and Chairman welcomed attendees, introduced board members, and outlined meeting procedures.
Independent auditors from Ernst & Young were introduced and made available for questions.
Corporate governance
Inspector of Election from Broadridge Financial Solutions confirmed a quorum and proper delivery of meeting materials.
Only stockholders of record as of April 14, 2026, or valid proxy holders, were eligible to vote.
Voting was conducted electronically, with polls open during the meeting.
Board and executive committee updates
Election of three Class I directors for terms expiring at the 2029 annual meeting was proposed.
Board unanimously recommended all director nominees.
Details on the 59% Class I director vote
Role of investor sentiment in pay decisions
Ratification results for Ernst & Young in 2026
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cartesian Therapeutics
- Q1 2026 net loss rose to $39.2M as R&D and CVR liability increased; cash at $120.4M.RNAC
Q1 202630 Apr 2026 - Virtual annual meeting to vote on directors, pay, and auditor ratification June 12, 2026.RNACProxy filing28 Apr 2026
- 2026 proxy covers director elections, executive pay, auditor ratification, and governance priorities.RNACProxy filing28 Apr 2026
- Descartes-08 delivers durable, outpatient mRNA cell therapy for autoimmune diseases, targeting major US markets.RNACCorporate presentation16 Apr 2026
- Net loss rose to $130.3M in 2025 as pivotal Descartes-08 trials advanced; cash runway extends to mid-2027.RNACQ4 20259 Mar 2026
- Up to $400M in securities, including $100M at-the-market stock, to fund mRNA autoimmune pipeline.RNACRegistration Filing16 Dec 2025
- Over 11 million shares registered for resale as mRNA cell therapy pipeline advances.RNACRegistration Filing16 Dec 2025
- Resale registration for 6.2M+ shares as mRNA cell therapy pipeline advances in autoimmune disease.RNACRegistration Filing16 Dec 2025
- Shareholders will vote on converting Series B Preferred Stock and potential meeting adjournment.RNACProxy Filing2 Dec 2025
Next Cartesian Therapeutics earnings date
Q2 20266 Aug, 2026
Cartesian Therapeutics
Next Cartesian Therapeutics earnings date
Q2 20266 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage